Taxotere Hair Loss: Breast Cancer Drug Causes Alopecia in Women
It was back during the late 1990s that the U. S. Food and Drug Administration (FDA) first approved injections of docetaxel (brand name Taxotere®) for different forms of cancer. Since that time, it’s been approved to treat breast, prostate, head, and neck cancers. Patients suffering from gastric cancers and non-small cell lung cancer have also been advised to use this drug. At present, many patients are now filing lawsuits claiming their doctors failed to inform them that using this drug could result in permanent (not just temporary) hair loss. While some observers have tried to minimize the significance of permanent hair...
Continue reading